Traitement combiné par photothérapie dynamique et implant intravitréen de dexaméthasone (Ozurdex®) pour un hémangiome choroïdien circonscrit

This case suggests that IDI (Ozurdex®) potentiates the effect of PDT with less risk of local side-effects than triamcinolone acetonide. Further evaluation of this protocol remains necessary. Nonetheless, combined treatment with injection of IDI followed 15 days later by PDT for the treatment of symptomatic CCH may prove to be a sound alternative to radiotherapy and may be more efficacious than PDT alone.